Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

Autor: Jacobson CA; Department of medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: caron_jacobson@dfci.harvard.edu., Chavez JC; University of South Florida H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sehgal AR; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., William BM; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Salles G; Department of Hematology and Medicine, Centre Hopitalier Lyon-Sud, University of Lyon, Pierre-Bénite, France., Munshi PN; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA., Casulo C; University of Rochester Medical Center, James P Wilmot Cancer Center, Rochester, NY, USA., Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., de Vos S; Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA, USA., Reshef R; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Leslie LA; John Theurer Cancer Center, Hackensack, NJ, USA., Yakoub-Agha I; Centre Hospitalier Régional Universitaire de Lille, INSERM U1286, Lille, France., Oluwole OO; Vanderbilt University Medical Center, Nashville, TN, USA., Fung HCH; Fox Chase Cancer Center, Philadelphia, PA, USA., Rosenblatt J; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA., Rossi JM; Kite Pharma, Santa Monica, CA, USA., Goyal L; Kite Pharma, Santa Monica, CA, USA., Plaks V; Kite Pharma, Santa Monica, CA, USA., Yang Y; Kite Pharma, Santa Monica, CA, USA., Vezan R; Kite Pharma, Santa Monica, CA, USA., Avanzi MP; Kite Pharma, Santa Monica, CA, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Jan; Vol. 23 (1), pp. 91-103. Date of Electronic Publication: 2021 Dec 08.

Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?

Autor: A., Pulsoni¹ alessandro.pulsoni@uniroma1.it, G. M., Assanto¹, M., Salvatori¹, P., Musiu¹, C., Luise¹, M., Passucci¹, G., Lapietra¹, L., Pappalardo¹, G., Annechini¹, G. M., D'Elia¹, M., Martelli¹, I., Del Giudice¹

Publikováno v: Mediterranean Journal of Hematology & Infectious Diseases. 2023, Vol. 15 Issue 1, p1-5. 5p.